# Probiome (Bacillus coagulans)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/probiome
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Bacillus coagulans, B. coagulans, Spore-forming lactic acid bacteria, Heat-stable probiotic, Soil-based probiotic, Bacillus coagulans spores

## Overview

Bacillus coagulans, marketed as Probiome, is a spore-forming lactic acid bacterium that produces L(+)-lactic acid via homofermentative [metabolism](/ingredients/condition/weight-management) to support [gut microbiome](/ingredients/condition/gut-health) balance. Its endospore structure allows it to survive gastric acid at pH 2.0 in the presence of bile salts and pepsin, enabling viable delivery to the intestinal tract.

## Health Benefits

• Enhanced gut survival through gastric acid resistance (survives pH 2.0 with bile salts/pepsin) - supported by in vitro studies only
• Lactic acid production for potential digestive support - based on strain characterization studies
• Spermidine synthesis from arginine for potential cellular health benefits - demonstrated in vitro for strain YF1
• Heat-stable formulation allowing room temperature storage - validated through production studies at 70-80°C
• Sustained intestinal release via specialized microsphere formulations - shown in 18-hour in vitro release studies

## Mechanism of Action

Bacillus coagulans germinates in the small intestine where it ferments sugars via the homofermentative pathway, producing L(+)-lactic acid that lowers luminal pH and inhibits pathogenic bacterial growth. The organism also synthesizes spermidine from arginine via the arginine decarboxylase and agmatine ureohydrolase enzymatic cascade, a polyamine implicated in [autophagy](/ingredients/condition/longevity) regulation and cellular renewal. Its dipicolinic acid-rich endospore coat confers resistance to proteolytic degradation by pepsin and pancreatin, distinguishing it from vegetative-form [probiotic](/ingredients/condition/gut-health)s.

## Clinical Summary

Evidence for Bacillus coagulans benefits derives primarily from in vitro acid-resistance assays and strain characterization studies, with limited robust human clinical trials specifically for the Probiome trade name. Small randomized controlled trials on related B. coagulans strains (e.g., GBI-30 6086) have used doses of 1–2 billion CFU/day in cohorts of 40–100 participants, reporting modest improvements in IBS symptom scores and stool consistency over 8 weeks. Survival data confirming viability at pH 2.0 with pepsin and bile salts is derived from in vitro challenge models, not confirmed in vivo transit studies. Overall evidence is preliminary; larger, strain-specific human trials are needed before definitive efficacy claims can be made.

## Nutritional Profile

Probiome contains Bacillus coagulans, a spore-forming lactic acid-producing bacterium, typically standardized to 1–6 billion CFU per serving depending on formulation. As a [probiotic](/ingredients/condition/gut-health), it has negligible macronutrient contribution (essentially zero calories, fat, protein, and carbohydrate per dose). Key bioactive outputs include: • L-(+)-lactic acid produced in situ in the intestinal lumen following spore germination, contributing to luminal pH modulation and potential competitive exclusion of pathogens • Spermidine (polyamine) synthesized endogenously by certain strains (e.g., YF1) from L-arginine via the agmatine deiminase pathway; in vitro yields reported in the low micromolar range, though in vivo intestinal concentrations remain uncharacterized • Short-chain fatty acids (SCFAs) — modest indirect contribution through cross-feeding with resident gut microbiota, predominantly acetate and butyrate at levels not precisely quantified for this species • Extracellular enzymes including α-amylase, protease, and lipase produced during vegetative growth that may assist macronutrient digestion • Bacteriocin-like substances (coagulin) with narrow-spectrum [antimicrobial](/ingredients/condition/immune-support) activity against select Gram-positive organisms • B-group vitamins — some Bacillus coagulans strains have demonstrated limited in vitro synthesis of riboflavin (B2) and folate (B9), though quantities are trace and not nutritionally significant. No appreciable mineral, fiber, or vitamin content is delivered by the spore preparation itself. Bioavailability notes: The spore form confers exceptional stability through gastric transit (demonstrated survival at pH 2.0 in simulated gastric fluid with pepsin and bile salts), with germination occurring in the duodenum/jejunum where vegetative cells become metabolically active. This gastric resistance is a key bioavailability advantage over many non-spore-forming probiotics (e.g., Lactobacillus spp.) that suffer 2–4 log reductions during gastric passage. Heat stability (survives up to 85°C for short durations) preserves viability without cold-chain requirements. However, the bioavailability of probiotic-derived metabolites (spermidine, lactic acid, bacteriocins) to the host systemically remains poorly characterized; most activity is presumed to be localized to the intestinal lumen and epithelial interface.

## Dosage & Preparation

No clinically studied dosage ranges are available from human trials. Production methods target spore counts via plating after heat treatment, with formulations using 15% starch and 5% trehalose as carriers, but specific CFU ranges for therapeutic use have not been established. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Bacillus coagulans is generally regarded as safe (GRAS status recognized by the FDA) and is well-tolerated in healthy adults at doses up to 5 billion CFU/day, with transient bloating or flatulence reported in a minority of users during initial supplementation. Individuals who are immunocompromised, post-surgical, or have serious underlying GI conditions should consult a physician before use, as spore-forming bacteria carry a theoretical risk of bacteremia in vulnerable populations. No significant drug interactions have been formally documented, though concurrent use with broad-spectrum antibiotics may reduce [probiotic](/ingredients/condition/gut-health) viability and efficacy. Pregnancy and lactation safety has not been established in controlled trials; use during these periods should be guided by a healthcare provider.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were found in the research dossier for Probiome-branded B. coagulans. Available studies focus exclusively on strain isolation, production methods, and in vitro characterization, with safety assessments limited to laboratory tests on novel strains like CGI314.

## Historical & Cultural Context

No traditional medicine context was found in the research. B. coagulans is described as a modern industrial [probiotic](/ingredients/condition/gut-health) widely used for lactic acid production, with strains isolated from contemporary sources like fermented foods and agricultural environments.

## Synergistic Combinations

Prebiotic fibers, [digestive enzyme](/ingredients/condition/gut-health)s, L-glutamine, zinc carnosine, slippery elm

## Frequently Asked Questions

### Can Bacillus coagulans survive stomach acid?

Yes, Bacillus coagulans forms heat- and acid-resistant endospores that have been shown in in vitro studies to remain viable at pH 2.0 in the presence of pepsin and bile salts for up to 2 hours. This structural advantage distinguishes it from fragile probiotic strains like Lactobacillus acidophilus, which suffer significant viability loss under the same gastric conditions. However, these findings come from laboratory challenge models, and confirmed in vivo human gastric transit survival data for the Probiome formulation specifically remain unpublished.

### What is the recommended dosage of Bacillus coagulans?

Clinical studies on B. coagulans strains have most commonly used doses ranging from 1 to 5 billion CFU (colony-forming units) per day, typically taken once daily with a meal to facilitate spore germination in the intestinal environment. The Probiome formulation should be dosed according to manufacturer specifications, as CFU counts and excipient matrices vary between products. No universal consensus dosage has been established by regulatory bodies, and individual needs may differ based on health status and intended use.

### What does spermidine from Bacillus coagulans do?

Bacillus coagulans can synthesize spermidine, a polyamine, from arginine via sequential enzymatic reactions involving arginine decarboxylase and agmatine ureohydrolase. Spermidine is a known inducer of autophagy — the cellular recycling process mediated through inhibition of EP300 acetyltransferase — and has been associated with longevity-related pathways in preclinical models. Whether the quantities of spermidine produced endogenously by gut-resident B. coagulans are sufficient to exert systemic cellular effects in humans has not been established by clinical data.

### Is Bacillus coagulans the same as Lactobacillus?

No, despite producing lactic acid like Lactobacillus species, Bacillus coagulans is taxonomically classified within the genus Bacillus (phylum Firmicutes) and is distinguished by its ability to form protective endospores — a trait absent in Lactobacillus. This sporulation capacity gives B. coagulans superior thermostability (surviving up to 50°C in some studies) and gastric acid resistance compared to non-spore-forming lactic acid bacteria. It was historically misclassified as Lactobacillus sporogenes, but molecular phylogenetic analysis confirmed its placement in the Bacillus genus.

### Who should not take Bacillus coagulans supplements?

Immunocompromised individuals — including those on immunosuppressive therapy, undergoing chemotherapy, or living with HIV/AIDS — should avoid Bacillus coagulans without medical supervision due to a theoretical risk of opportunistic infection from spore-forming bacteria. People with short bowel syndrome, central venous catheters, or recent abdominal surgery carry additional risk factors for probiotic-related bacteremia. Pregnant or breastfeeding individuals should also seek physician guidance, as controlled safety studies in these populations are lacking for B. coagulans specifically.

### How does Probiome (Bacillus coagulans) differ from other probiotic strains in terms of heat stability?

Probiome's Bacillus coagulans formulation is heat-stable and can be stored at room temperature without requiring refrigeration, unlike many Lactobacillus-based probiotics that are temperature-sensitive. This stability makes it more convenient for travel and storage, and reduces the risk of potency loss from temperature fluctuations during shipping or home storage. The spore-forming nature of Bacillus coagulans naturally confers this superior thermal resilience.

### What clinical evidence exists for Probiome (Bacillus coagulans) effectiveness in digestive health?

Probiome's efficacy is primarily supported by in vitro studies demonstrating its ability to produce lactic acid and survive gastric conditions, though robust human clinical trials are limited. The strain (YF1) has been characterized for its spermidine synthesis capacity in laboratory settings, but translating these benefits to real-world digestive outcomes requires further clinical investigation. Most available evidence focuses on strain characterization rather than large-scale human efficacy studies.

### Can Probiome (Bacillus coagulans) be taken alongside other supplements or medications without interaction concerns?

Bacillus coagulans is generally considered safe to combine with most supplements and medications due to its localized action in the digestive tract, though immunocompromised individuals should consult their healthcare provider before use. As with any probiotic, specific drug interactions are not extensively documented in clinical literature, making personalized medical advice important for those on multiple medications. Always inform your healthcare provider about probiotic supplementation, particularly if taking immunosuppressants or antibiotics.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*